In small cross-sectional studies, lower concentrations of both vitamin E and vitamin E/cholesterol-ratio have been reported in stable MS patients compared to controls [18], and also in MS patients during exacerbation compared to stable MS patients with or without IFNB treatment, and controls [9], [19], [20]. The gene discussed is IFNB1; the disease is myeloid sarcoma.